Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting

Table 4 Migraine associated with menstruation

	Baseline	Week 12	Month 6	Month 9	Month 12	LOCF
	N = 302	N = 272	N = 261	N = 203	N = 183	N = 235
Patients N (%)
Women with documented visits^a	266 (88.1)	240 (88.2)	230 (88.1)	180 (88.7)	164 (89.6)	235 (100)
Women with migraine attacks^b	259 (97.4)	177 (73.8)	196 (85.2)	134 (74.4)	119 (72.6)	187 (79.6)
Association with menstruation^c
No	165 (63.7)	137 (77.4)	145 (74.0)	93 (69.4)	88 (73.9)
Yes	94 (36.3)	35 (19.8)	45 (23.0)	40 (29.9)	31 (26.1)	42 (22.5)^d

^aPercentages relate to the number of patients with documented visits
^bPercentages relate to the number of women with documented visits
^cPercentages relate to the number of women with migraine attacks
^dTotal count of women for whom migraine attacks associated with menstruation were observed for the first time after treatment with topiramate

ISSN: 1129-2377